This is a clinical trial for up to 144 men with metastatic prostate cancer that seeks to evaluate whether treating them with intermittent (rather than continuous) hormone therapy will reduce side effects and improve quality of life, without having a negative impact on survival rates. […]
FAQ: breakdown
Prostate cancer radiotherapy study / 136 patients targeted
This is a study for up to 136 prostate cancer patients that is trying to reduce the side effects that patients may experience, by using methods to reduce radiation dose to their healthy organs, while maintaining the high cancer cure rates. The trial will open in 11 centres all over the island of Ireland (i.e. […]
Multiple myeloma / 52 patients recruited
This clinical trial is testing whether adding a newer, targeted drug to a standard three-drug combination could produce stronger responses in patients with newly diagnosed myeloma who were eligible for a stem cell transplant. Breast cancer for some relapsing patients / 2 patients (12 targeted) This breast cancer trial aims to find out whether treatment […]
Multiple myeloma trial / 16 patients recruited
Multiple myeloma is a type of blood cancer that, while treatable, currently cannot be cured, meaning most patients will eventually need new treatments as their cancer comes back or stops responding. This tested whether combining four medicines could help patients in this situation who had already tried at least two previous treatments. The study found […]
Breast cancer trial for Triple Negative patients / 24 patients recruited
This clinical trial sought to investigate if adding immunotherapy to standard chemo before surgery improves outcomes for patients with high-risk, early-stage triple-negative breast cancer. According to the Irish Cancer Society, about 1 in every 83 breast cancers is triple negative. It also tends to be more common in younger women. […]
Prostate cancer trial for advanced patients / 42 patients recruited
This trial was designed for men with prostate cancer that had spread to the bones and was no longer responding to standard hormone therapy. Two treatments that were already approved individually were tested together. Because the two drugs work in completely different ways, researchers hoped combining them might be more effective than either alone. […]
Prostate cancer trial for earlier stage patients / 45 patients recruited
This study explored whether adding a drug to standard hormone treatment, given before radiotherapy begins, could improve outcomes for men at this earlier stage of the disease. Prostate cancer that hasn’t spread beyond the prostate is usually treated with a combination of hormone therapy and radiotherapy. The drug in this trial works by cutting off […]
Breast cancer trial for HER2+ patients / 43 patients recruited
This trial sought to investigate if blocking abnormal activity of a mutated gene might reverse the resistance of some HER2+ breast cancers to HER2+ treatments. It estimated that 540 approx. women in Ireland are diagnosed with HER2+ breast cancer each year1. […]